Search Keyword:


Search option:


IID00525
UniprotO14920
ProteinInhibitor of nuclear factor kappa-B kinase subunit beta
GeneIKBKB
OrganismHomo sapiens
Sequence LLPS PhaSepDB
PhaSePro
LLPSDB
DrLLPS
Network xml rdf
Structure
Experiment
  :order   disorder   conflict   PDB cluster   ProS   Pfam Domain   SEG
756
 order/disorder by at least rule
     disorder by at least rule
     order by at least rule
 order/disorder by majority rule
Seq 2-669 Homo dimer :
 Evidence X-RAY 4kik B Reference
       Region 4kik B 2-173 order
       Region 4kik B 174-176 disorder
       Region 4kik B 177-372 order
       Region 4kik B 373-375 disorder
       Region 4kik B 376-550 order
       Region 4kik B 551-557 disorder
       Region 4kik B 558-663 order
       Region 4kik B 664-664 disorder
 Evidence X-RAY 4kik A Reference
       Region 4kik A 2-8 disorder
       Region 4kik A 9-23 order
       Region 4kik A 24-26 disorder
       Region 4kik A 27-84 order
       Region 4kik A 85-88 disorder
       Region 4kik A 89-169 order
       Region 4kik A 170-179 disorder
       Region 4kik A 180-372 order
       Region 4kik A 373-375 disorder
       Region 4kik A 376-400 order
       Region 4kik A 401-403 disorder
       Region 4kik A 404-501 order
       Region 4kik A 502-507 disorder
       Region 4kik A 508-550 order
       Region 4kik A 551-557 disorder
       Region 4kik A 558-663 order
       Region 4kik A 664-664 disorder
 Evidence X-RAY 4e3c E Reference
       Region 4e3c E 11-15 disorder
       Region 4e3c E 16-286 order
       Region 4e3c E 287-289 disorder
       Region 4e3c E 290-373 order
       Region 4e3c E 374-382 disorder
       Region 4e3c E 383-394 order
       Region 4e3c E 395-400 disorder
       Region 4e3c E 401-550 order
       Region 4e3c E 551-558 disorder
       Region 4e3c E 559-665 order
       Region 4e3c E 666-669 disorder
 Evidence X-RAY 4e3c D Reference
       Region 4e3c D 11-15 disorder
       Region 4e3c D 16-286 order
       Region 4e3c D 287-289 disorder
       Region 4e3c D 290-373 order
       Region 4e3c D 374-382 disorder
       Region 4e3c D 383-394 order
       Region 4e3c D 395-400 disorder
       Region 4e3c D 401-550 order
       Region 4e3c D 551-558 disorder
       Region 4e3c D 559-665 order
       Region 4e3c D 666-669 disorder
 Evidence X-RAY 4e3c C Reference
       Region 4e3c C 11-15 disorder
       Region 4e3c C 16-286 order
       Region 4e3c C 287-289 disorder
       Region 4e3c C 290-373 order
       Region 4e3c C 374-382 disorder
       Region 4e3c C 383-394 order
       Region 4e3c C 395-400 disorder
       Region 4e3c C 401-550 order
       Region 4e3c C 551-558 disorder
       Region 4e3c C 559-665 order
       Region 4e3c C 666-669 disorder
 Evidence X-RAY 4e3c B Reference
       Region 4e3c B 11-15 disorder
       Region 4e3c B 16-286 order
       Region 4e3c B 287-289 disorder
       Region 4e3c B 290-373 order
       Region 4e3c B 374-382 disorder
       Region 4e3c B 383-394 order
       Region 4e3c B 395-400 disorder
       Region 4e3c B 401-665 order
       Region 4e3c B 666-669 disorder
 Evidence X-RAY 4e3c F Reference
       Region 4e3c F 11-15 disorder
       Region 4e3c F 16-286 order
       Region 4e3c F 287-289 disorder
       Region 4e3c F 290-373 order
       Region 4e3c F 374-382 disorder
       Region 4e3c F 383-394 order
       Region 4e3c F 395-400 disorder
       Region 4e3c F 401-550 order
       Region 4e3c F 551-558 disorder
       Region 4e3c F 559-665 order
       Region 4e3c F 666-669 disorder
 Evidence X-RAY 4e3c A Reference
       Region 4e3c A 11-15 disorder
       Region 4e3c A 16-286 order
       Region 4e3c A 287-289 disorder
       Region 4e3c A 290-373 order
       Region 4e3c A 374-382 disorder
       Region 4e3c A 383-394 order
       Region 4e3c A 395-400 disorder
       Region 4e3c A 401-550 order
       Region 4e3c A 551-558 disorder
       Region 4e3c A 559-665 order
       Region 4e3c A 666-669 disorder
Seq 701-730 Hetero dimer : IID00526Complex,IID00745Complex
 Evidence X-RAY 3brt C Reference
       Region 3brt C 701-730 order
Seq 701-730 Hetero dimer : IID00526Complex,IID00745Complex
 Evidence X-RAY 3brt C Reference
       Region 3brt C 701-730 order
Seq 701-730 Hetero dimer : IID00526Complex,IID00745Complex
 Evidence X-RAY 3brt A Reference
       Region 3brt A 701-704 disorder
       Region 3brt A 705-730 order
Seq 701-730 Hetero dimer : IID00526Complex,IID00745Complex
 Evidence X-RAY 3brt A Reference
       Region 3brt A 701-704 disorder
       Region 3brt A 705-730 order
Seq 701-745 Hetero tetramer : IID00745Complex
 Evidence X-RAY 3brv C Reference
       Region 3brv C 701-701 disorder
       Region 3brv C 702-743 order
       Region 3brv C 744-745 disorder
 Evidence X-RAY 3brv A Reference
       Region 3brv A 701-704 disorder
       Region 3brv A 705-743 order
       Region 3brv A 744-745 disorder
Seqphosphorylation
    689-689 Phosphoserine; by autocatalysis
    692-692 Phosphoserine; by autocatalysis
    682-682 Phosphoserine; by autocatalysis
    675-675 Phosphoserine; by autocatalysis
    672-672 Phosphoserine
    697-697 Phosphoserine; by autocatalysis
    675-675 Phosphoserine
    670-670 Phosphoserine; by autocatalysis
    181-181 Phosphoserine; by TBK1
    177-177 Phosphoserine; by TBK1 and PKC/PRKCZ
    695-695 Phosphoserine; by autocatalysis
    750-750 Phosphoserine; by autocatalysis
    740-740 Phosphoserine; by autocatalysis
    705-705 Phosphoserine; by autocatalysis
    733-733 Phosphoserine; by autocatalysis
Seqacetylation
    180-180 (Microbial infection) O-acetylthreonine; by Yersinia YopJ
 
Prediction
NeProc
Disorder 1-8,502-506,663-701,730-756
Order 9-501,507-662,702-729
ProS 502-506,699-701,730-743,750-756
AlphaFold
Disorder 1-4,6-8,24-26,170-170,172-184,374-374,551-558,664-709,712-712,719-720,722-756
Order 5-5,9-23,27-169,171-171,185-373,375-550,559-663,710-711,713-718,721-721
Pfam Hmmer
PF00069 15-312 2.9e-49
SEG 256-267
Function
Function in SwissProt
Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses (PubMed:30337470). Acts as part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation. Phosphorylates inhibitors of NF-kappa-B on 2 critical serine residues. These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome. In turn, free NF-kappa-B is translocated into the nucleus and activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis. In addition to the NF-kappa-B inhibitors, phosphorylates several other components of the signaling pathway including NEMO/IKBKG, NF-kappa-B subunits RELA and NFKB1, as well as IKK-related kinases TBK1 and IKBKE (PubMed:11297557, PubMed:20410276). IKK-related kinase phosphorylations may prevent the overproduction of inflammatory mediators since they exert a negative regulation on canonical IKKs. Phosphorylates FOXO3, mediating the TNF-dependent inactivation of this pro-apoptotic transcription factor (PubMed:15084260). Also phosphorylates other substrates including NCOA3, BCL10 and IRS1 (PubMed:17213322). Within the nucleus, acts as an adapter protein for NFKBIA degradation in UV-induced NF-kappa-B activation (PubMed:11297557). Phosphorylates RIPK1 at 'Ser-25' which represses its kinase activity and consequently prevents TNF-mediated RIPK1-dependent cell death (By similarity). Phosphorylates the C-terminus of IRF5, stimulating IRF5 homodimerization and translocation into the nucleus (PubMed:25326418).